Abstract
Purpose
To evaluate the clinical impact on progression and recurrence according to presence and absence of a muscle layer, we conducted a retrospective, multicenter study.
Methods
We retrospectively reviewed 247 patients who received transurethral resection (TUR) of bladder tumors and were pathologically diagnosed as having T1G3 bladder cancer from 1990 to 2009. We ruled out 8 patients who received immediate cystectomy and analyzed the remaining 239 T1G3 patients. Patients who had invasion to the prostatic urethra and patients who underwent a second TUR were not included.
Results
TUR specimens from 194 patients were confirmed to have a definite muscle layer and those from 45 did not. The median follow-up period was 53 months, ranging from 3 to 181 months. The progression-free survival rates at 5 years after TUR were 91.1 % for patients who had a muscle layer in their specimen and 77.3 % for those who did not (p = 0.005, log-rank test). Multivariate analysis indicated that the absence of a muscle layer was a risk factor for progression (p = 0.006, Cox proportional hazards analysis).
Conclusions
Patients without a muscle layer in the specimen had high risk for progression. The initial TUR must have a muscle layer in the specimen. Variations of progression rates in previous studies might be due to different proportions of patients who had a muscle layer in TUR specimens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- SUOC:
-
Sapporo Medical University Urologic Oncology Consortium
- TUR:
-
Transurethral resection
References
Dutta SC, Smith JA Jr, Shappell SB et al (2001) Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166:490–493
Shahin O, Thalmann GN, Rentsch C et al (2003) A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette–Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 169:96–100
Denzinger S, Otto W, Fritsche HM et al (2007) Bladder sparing approach for initial T1G3 bladder cancer: do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients. Int J Urol 14:995–999
Moonen PMJ, Balken-Ory B, Kiemeney LALM et al (2007) Prognostic value of p53 for high risk superficial bladder cancer with long-term followup. J Urol 177:80–83
Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19:666–675
Shindo T, Masumori N, Fukuta F et al (2010) Is T1G3 bladder cancer having a definite muscle layer in TUR specimens a highly progressive disease? Jpn J Clin Oncol 40:153–156
Kulkarmi GS, Hakenberg OW, Gschwend JE et al (2010) An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol 57:60–70
Sylvester RJ, Meijden A, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466–477
Gohji K, Nomi M, Okamoto M et al (1999) Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder. Urology 53:308–313
Park J, Song C, Hong JH et al (2009) Prognostic significance of non-papillary tumor morphology as a predictor of cancer progression and survival in patients with primary T1G3 bladder cancer. World J Urol 27:277–283
Mariappan P, Zachou A, Grigor KM (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57:843–849
Herr HW (1999) The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162:74–76
Kim W, Song C, Park S et al (2012) Value of immediate second resection of tumor bed to improve the effectiveness of transurethral resection of bladder tumor. J Endourol 26:1059–1064
Divrik RT, Sahin AF, Yildirim U et al (2010) Impact of routine second transurethral resection on the long term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomized clinical trial. Eur Urol 58:185–190
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shindo, T., Masumori, N., Kitamura, H. et al. Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC). World J Urol 32, 1281–1285 (2014). https://doi.org/10.1007/s00345-013-1205-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-013-1205-1